HR Execs on the Move

Emergent BioSolutions

www.emergentbiosolutions.com

 
Emergent BioSolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. We develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Eric de los Santos
Assistant General Counsel, Labor and Profile
Greg Terry
North American Director of Sales and Business Development Profile
David Maust
Director Supply Chain Profile
Shannon Beaty
Director of Vaccines R&D Profile
Lo Vang
Senior Director, Translational R&D Profile

Jobs

VP, Chief Information Security Officer

Emergent BioSolutions Remote
Details here:
https://careers.emergentbiosolutions.com/job/Gaithersburg-Vice-President%2C-Chief-Information-Security-Officer-Remote-MD-20879/1200080000/?feedId=306800&utm_source=Indeed&utm_campaign=EmergentBio_Indeed&jobPipeline=Indeed

Similar Companies

Antibacterial Resistance Leadership Group (ARLG)

ARLG addresses antibacterial resistance through innovative clinical trial design, unique access to clinically well-characterized bacteria, and opportunities for early-stage investigators.

IMV

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases.

Wichita Radiological Group, P.A.

Wichita Radiological Group, P.A. is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cellartis AB

Cellartis AB is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TrovaGene

Trovagene is a molecular diagnostics company providing precise, noninvasive urine and blood testing for detecting and monitoring oncogene mutations. By utilizing proprietary technology that analyzes circulating tumor DNA, Trovagene testing offers critical data that may help inform cancer treatment decisions, giving physicians and patients monitoring options beyond biopsy or imaging.